UM

Browse/Search Results:  1-8 of 8 Help

Selected(0)Clear Items/Page:    Sort:
Nanomedicines modulating tumor immunosuppressive cells to enhance cancer immunotherapy Journal article
Acta Pharmaceutica Sinica B, 2020,Volume: 10,Issue: 11,Page: 2054-2074
Authors:  Zhu,Yuefei;  Yu,Xiangrong;  Thamphiwatana,Soracha D.;  Zheng,Ying;  Pang,Zhiqing
Favorite |  | TC[WOS]:6 TC[Scopus]:7 | Submit date:2021/03/01
Cancer immunotherapy  Drug delivery  Nanomedicine  Tumor immunosuppressive microenvironment  
Transforming the spleen into a liver-like organ in vivo Journal article
Science Advances, 2020,Volume: 6,Issue: 24
Authors:  Wang,Lintao;  Wang,Chunming;  Wang,Zhenzhen;  Gan,Jingjing;  Liu,Chunyan;  Xia,Suhua;  Niu,Yiming;  Chen,Dianhua;  Zhang,Junfeng;  Dong,Lei
Favorite |  | TC[WOS]:1 TC[Scopus]:1 | Submit date:2021/03/02
Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor-An Opportunity for Cancer Treatment Journal article
Cells, 2019,Volume: 9,Issue: 1
Authors:  Al-Hatamleh,Mohammad A.I.;  E A R,Engku Nur Syafirah;  Boer,Jennifer C.;  Ferji,Khalid;  Six,Jean Luc;  Chen,Xin;  Elkord,Eyad;  Plebanski,Magdalena;  Mohamud,Rohimah
Favorite |  | TC[WOS]:7 TC[Scopus]:5 | Submit date:2021/03/01
immunosuppressive  immunotherapy  nanoparticles  regulatory T cells  TNF  
Self-Supplied Tumor Oxygenation through Separated Liposomal Delivery of H2O2 and Catalase for Enhanced Radio-Immunotherapy of Cancer Journal article
Nano Letters, 2018,Volume: 18,Issue: 10,Page: 6360-6368
Authors:  Song X.;  Xu J.;  Liang C.;  Chao Y.;  Jin Q.;  Wang C.;  Chen M.;  Liu Z.
Favorite |  | TC[WOS]:104 TC[Scopus]:107 | Submit date:2018/12/27
check-point-blockade immunotherapy  radiotherapy  self-supplied oxygen delivery  Tumor hypoxia  
Engineering a Tumor Microenvironment-Mimetic Niche for Tissue Regeneration with Xenogeneic Cancer Cells Journal article
ADVANCED SCIENCE, 2018,Volume: 5,Issue: 3
Authors:  Wang, Zhenzhen;  Wang, Chunming;  Abudukeremu, Ayipaxia;  Rui, Xiaying;  Liu, Shang;  Zhang, Xiaoyi;  Zhang, Min;  Zhang, Junfeng;  Dong, Lei
Favorite |  | TC[WOS]:4 TC[Scopus]:5 | Submit date:2018/10/30
Intrinsic Morphology  Physiological Functions  Regenerative Medicine  Tumor Microenvironment-mimetic Niche  Xenogeneic Cancer Cells  
Tumor vasculature normalization by orally fed erlotinib to modulate the tumor microenvironment for enhanced cancer nanomedicine and immunotherapy Journal article
BIOMATERIALS, 2017,Volume: 148,Page: 69-80
Authors:  Chen, Qian;  Xu, Ligeng;  Chen, Jiawen;  Yang, Zhijuan;  Liang, Chao;  Yang, Yu;  Liu, Zhuang
Favorite |  | TC[WOS]:50 TC[Scopus]:51 | Submit date:2018/10/30
Erlotinib  Vascular normalization  Tumor microenvironment  Nanomedicine  Immunotherapy  
A Jak2-selective inhibitor potently reverses the immune suppression by modulating the tumor microenvironment for cancer immunotherapy Journal article
BIOCHEMICAL PHARMACOLOGY, 2017,Volume: 145,Page: 132-146
Authors:  He, Wei;  Zhu, Yi;  Mu, Ruoyu;  Xu, Jinzhi;  Zhang, Xiaoyi;  Wang, Chunming;  Li, Qiu;  Huang, Zhen;  Zhang, Junfeng;  Pan, Yi;  Han, Jianlin;  Dong, Lei
Favorite |  | TC[WOS]:9 TC[Scopus]:8 | Submit date:2018/10/30
Tumor Associated Macrophages  Regulatory t Cells  Jak2-stat3 Pathway  Tumor Immunotherapy  
Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment Journal article
Proceedings of the National Academy of Sciences of the United States of America, 2009,Volume: 106,Issue: 46,Page: 19455-19460
Authors:  Weiss J.M.;  Back T.C.;  Scarzello A.J.;  Subleski J.J.;  Hall V.L.;  Stauffer J.K.;  Chen X.;  Micic D.;  Alderson K.;  Murphy W.J.;  Wiltrout R.H.
Favorite |  | TC[WOS]:43 TC[Scopus]:46 | Submit date:2018/11/06
Cd40  Chemokines  Tumor Immunotherapy